So much insulin, so much hypoglycemia

JAMA Internal Medicine

Volumn 174, Issue 5, 2014, Pages 686-688

  Lee, Sei J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT;

CARDIOVASCULAR RISK; DEMENTIA; DRUG SURVEILLANCE PROGRAM; EMERGENCY WARD; GLYCEMIC CONTROL; HEALTH CARE PERSONNEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN HYPOGLYCEMIA; INSULIN TREATMENT; INTERVIEW; LIFE EXPECTANCY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL;

EMERGENCY SERVICE, HOSPITAL; FEMALE; HOSPITALIZATION; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MEDICATION ERRORS;

EID: 84899837737     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.13307     Document Type: Note

References (11)

1. Whitmer RA, Karter AJ, Yaffe K, Quesenberry CP Jr, Selby JV. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA. 2009;301(15):1565-1572.
2. Geller AI, Shehab N, Lovegrove MC, et al. National estimates of insulin-related hypoglycemia and errors leading to emergency department visits and hospitalizations [published online March 10, 2014]. JAMA Intern Med. 2013. doi:10.1001 /jamainternmed.2014.136.
3. Donnelly LA, Morris AD, Frier BM, et al. Frequency and predictors of hypoglycaemia in type 1 and insulin-treated type 2 diabetes: a population-based study. Diabet Med. 2005;22(6):749-755.
4. Shorr RI, RayWA, Daugherty JR, Griffin MR. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med. 1997;157(15):1681-1686.
5. Go AS, Mozaffarian D, Roger VL, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics - 2013 update: a report from the American Heart Association. Circulation. 2013;127(1):143-152.
6. Aron D, Pogach L. Transparency standards for diabetes performance measures. JAMA. 2009;301(2):210-212.
7. ACCORD Investigators. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545-2559
8. American Diabetes Association. Standards of medical care in diabetes - 2014. Diabetes Care. 2014;37(suppl 1):S14-S80.
9. Lee SJ,Walter LC. Quality indicators for older adults: preventing unintended harms. JAMA. 2011;306(13):1481-1482.
10. Pogach L, Aron D. The other side of quality improvement in diabetes for seniors: a proposal for an overtreatment glycemic measure. Arch Intern Med. 2012;172(19):1510-1512.
11. Lee SJ, Eng C. Goals of glycemic control in frail older patients with diabetes. JAMA. 2011;305(13):1350-1351.